247 related articles for article (PubMed ID: 16267233)
1. Development of a femtomolar-acting humanin derivative named colivelin by attaching activity-dependent neurotrophic factor to its N terminus: characterization of colivelin-mediated neuroprotection against Alzheimer's disease-relevant insults in vitro and in vivo.
Chiba T; Yamada M; Hashimoto Y; Sato M; Sasabe J; Kita Y; Terashita K; Aiso S; Nishimoto I; Matsuoka M
J Neurosci; 2005 Nov; 25(44):10252-61. PubMed ID: 16267233
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotection against neurodegenerative diseases: development of a novel hybrid neuroprotective peptide Colivelin.
Chiba T; Nishimoto I; Aiso S; Matsuoka M
Mol Neurobiol; 2007 Feb; 35(1):55-84. PubMed ID: 17519506
[TBL] [Abstract][Full Text] [Related]
3. Humanin and colivelin: neuronal-death-suppressing peptides for Alzheimer's disease and amyotrophic lateral sclerosis.
Matsuoka M; Hashimoto Y; Aiso S; Nishimoto I
CNS Drug Rev; 2006; 12(2):113-22. PubMed ID: 16958985
[TBL] [Abstract][Full Text] [Related]
4. Amyloid-beta causes memory impairment by disturbing the JAK2/STAT3 axis in hippocampal neurons.
Chiba T; Yamada M; Sasabe J; Terashita K; Shimoda M; Matsuoka M; Aiso S
Mol Psychiatry; 2009 Feb; 14(2):206-22. PubMed ID: 18813209
[TBL] [Abstract][Full Text] [Related]
5. Detailed characterization of neuroprotection by a rescue factor humanin against various Alzheimer's disease-relevant insults.
Hashimoto Y; Niikura T; Ito Y; Sudo H; Hata M; Arakawa E; Abe Y; Kita Y; Nishimoto I
J Neurosci; 2001 Dec; 21(23):9235-45. PubMed ID: 11717357
[TBL] [Abstract][Full Text] [Related]
6. Activity-dependent neurotrophic factor, ADNF, determines the structure characteristics of Colivelin, a fusion protein of ADNF9 and Humanin analog.
Arakawa T; Niikura T; Arisaka F; Kita Y
J Pept Sci; 2008 May; 14(5):631-6. PubMed ID: 17994638
[TBL] [Abstract][Full Text] [Related]
7. Colivelin prolongs survival of an ALS model mouse.
Chiba T; Yamada M; Sasabe J; Terashita K; Aiso S; Matsuoka M; Nishimoto I
Biochem Biophys Res Commun; 2006 May; 343(3):793-8. PubMed ID: 16564029
[TBL] [Abstract][Full Text] [Related]
8. A humanin derivative, S14G-HN, prevents amyloid-beta-induced memory impairment in mice.
Tajima H; Kawasumi M; Chiba T; Yamada M; Yamashita K; Nawa M; Kita Y; Kouyama K; Aiso S; Matsuoka M; Niikura T; Nishimoto I
J Neurosci Res; 2005 Mar; 79(5):714-23. PubMed ID: 15678515
[TBL] [Abstract][Full Text] [Related]
9. Colivelin Ameliorates Impairments in Cognitive Behaviors and Synaptic Plasticity in APP/PS1 Transgenic Mice.
Wu M; Shi H; He Y; Yuan L; Qu X; Zhang J; Wang Z; Cai H; Qi J
J Alzheimers Dis; 2017; 59(3):1067-1078. PubMed ID: 28731445
[TBL] [Abstract][Full Text] [Related]
10. The multiple T-maze in vivo testing of the neuroprotective effect of humanin analogues.
Kunesová G; Hlavácek J; Patocka J; Evangelou A; Zikos C; Benaki D; Paravatou-Petsotas M; Pelecanou M; Livaniou E; Slaninova J
Peptides; 2008 Nov; 29(11):1982-7. PubMed ID: 18647630
[TBL] [Abstract][Full Text] [Related]
11. Nasal Colivelin treatment ameliorates memory impairment related to Alzheimer's disease.
Yamada M; Chiba T; Sasabe J; Terashita K; Aiso S; Matsuoka M
Neuropsychopharmacology; 2008 Jul; 33(8):2020-32. PubMed ID: 17928813
[TBL] [Abstract][Full Text] [Related]
12. Protective Effects of Colivelin Against Alzheimer's Disease in a PDAPP Mouse Model.
Yin R; Yin K; Guo Z; Zhang Z; Chen L; Cao L; Li Y; Wei Y; Fu X; Shi X
Cell Physiol Biochem; 2016; 38(3):1138-46. PubMed ID: 26964005
[TBL] [Abstract][Full Text] [Related]
13. Colivelin ameliorates amyloid β peptide-induced impairments in spatial memory, synaptic plasticity, and calcium homeostasis in rats.
Wu MN; Zhou LW; Wang ZJ; Han WN; Zhang J; Liu XJ; Tong JQ; Qi JS
Hippocampus; 2015 Mar; 25(3):363-72. PubMed ID: 25332198
[TBL] [Abstract][Full Text] [Related]
14. The structure analysis of Humanin analog, AGA-(C8R)HNG17, by circular dichroism and sedimentation equilibrium: comparison with the parent molecule.
Arisaka F; Niikura T; Arakawa T; Kita Y
Int J Biol Macromol; 2008 Aug; 43(2):88-93. PubMed ID: 18456318
[TBL] [Abstract][Full Text] [Related]
15. Humanin: after the discovery.
Niikura T; Chiba T; Aiso S; Matsuoka M; Nishimoto I
Mol Neurobiol; 2004 Dec; 30(3):327-40. PubMed ID: 15655255
[TBL] [Abstract][Full Text] [Related]
16. New labeled derivatives of the neuroprotective peptide colivelin: synthesis, characterization, and first in vitro and in vivo applications.
Kostomoiri M; Zikos C; Benaki D; Triantis C; Sagnou M; Paravatou-Petsotas M; Papadaki A; Boleti H; Papadopoulos M; Pirmettis I; Pelecanou M; Livaniou E
Arch Biochem Biophys; 2015 Feb; 567():83-93. PubMed ID: 25575783
[TBL] [Abstract][Full Text] [Related]
17. [Gly14]-Humanin Protects Against Amyloid β Peptide-Induced Impairment of Spatial Learning and Memory in Rats.
Yuan L; Liu XJ; Han WN; Li QS; Wang ZJ; Wu MN; Yang W; Qi JS
Neurosci Bull; 2016 Aug; 32(4):374-82. PubMed ID: 27306655
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of neuroprotection by a novel rescue factor humanin from Swedish mutant amyloid precursor protein.
Hashimoto Y; Ito Y; Niikura T; Shao Z; Hata M; Oyama F; Nishimoto I
Biochem Biophys Res Commun; 2001 May; 283(2):460-8. PubMed ID: 11327724
[TBL] [Abstract][Full Text] [Related]
19. Humanin antagonists: mutants that interfere with dimerization inhibit neuroprotection by Humanin.
Hashimoto Y; Terashita K; Niikura T; Yamagishi Y; Ishizaka M; Kanekura K; Chiba T; Yamada M; Kita Y; Aiso S; Matsuoka M; Nishimoto I
Eur J Neurosci; 2004 May; 19(9):2356-64. PubMed ID: 15128389
[TBL] [Abstract][Full Text] [Related]
20. Targeting the JAK2/STAT3 axis in Alzheimer's disease.
Chiba T; Yamada M; Aiso S
Expert Opin Ther Targets; 2009 Oct; 13(10):1155-67. PubMed ID: 19663649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
